Furthermore, DIRC3 loss results in a concomitant increase in SOX10 mediated repression of IGFBP5. These data suggest that DIRC3 acts at its site of synthesis to modify chromatin structure and control IGFBP5 regulatory element activity in melanoma. Here, IGFBP5 is linked to melanoma.